Gastrointestinal and Other Cancers Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Therapeutic Conventional Surgery NCT00118040 National Cancer Institute (NCI) Active, not recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Laboratory Biomarker Analysis, Questionnaire Administration, Simvastatin, Placebo Administration NCT02968810 National Cancer Institute (NCI) Recruiting
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin NCT02743364 National Cancer Institute (NCI) Active, not recruiting
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine, Quality-of-Life Assessment, Saline NCT02134925 National Cancer Institute (NCI) Active, not recruiting

Pages